doi:10.1007/s12250-014-3485-z

[1]
Ling Su, Xia Zhou, Dan Yuan, Hong Yang, Dongbing Wei, Guangmin Qin, Shu Liang, 2014: Prevalence and patterns of drug-resistance mutations among HIV-1 patients infected with CRF07_BC strains in Sichuan province, China, Virologica Sinica, 29, 237-241. doi: 10.1007/s12250-014-3487-x
[2]
Ningning Ge, Jin Sun, Zhihua Liu, Jiayi Shu, Huimin Yan, Zhihua Kou, Yu Wei, Xia Jin, 2022: An mRNA vaccine encoding Chikungunya virus E2-E1 protein elicits robust neutralizing antibody responses and CTL immune responses, Virologica Sinica, 37, 266-276. doi: 10.1016/j.virs.2022.01.032
[3]
黄德东, 孙永涛, 翟嵩, 赵曙光, 王少扬, 庄严, 李新红, 康文臻, , , , 2006: Specific Cytotoxic T Lymphocytes Responses to Human Immunodeficiency Virus Type 1 Accessory Proteins, Virologica Sinica, 21, 529-535.
[4]
Chunpeng Yang, Rui Gong, Natalia de Val, 2019: Development of Neutralizing Antibodies against Zika Virus Based on Its Envelope Protein Structure, Virologica Sinica, 34, 168-174. doi: 10.1007/s12250-019-00093-5
[5]
Dezhi Li, Jie Liu, Li Zhang, Tianshu Xu, Junheng Chen, Liping Wang, Qi Zhao, 2015: N-terminal residues of an HIV-1 gp41 membrane-proximal external region antigen influence broadly neutralizing 2F5-like antibodies, Virologica Sinica, 30, 449-456. doi: 10.1007/s12250-015-3664-6
[6]
李红霞, 孟小林*, 徐进平, 王健, 鲁伟, 曹旭, 2004: Expression of Recombinant Envelope Proteins VP19 and VP28 of WSSV and Preparation of Neutralizing Antibody, Virologica Sinica, 19, 587-590.
[7]
Dan Luo, Yuanjiu Miao, Xianliang Ke, Zhongyuan Tan, Chun Hu, Penghui Li, Ting Wang, Yuan Zhang, Jianhong Sun, Yan Liu, Hanzhong Wang, Zhenhua Zheng, 2020: Baculovirus Surface Display of Zika Virus Envelope Protein Protects against Virus Challenge in Mouse Model, Virologica Sinica, 35, 637-650. doi: 10.1007/s12250-020-00238-x
[8]
Zhichao Yin, Yuanyuan Wu, Rui Zhu, Longfa Xu, Yu Lin, Hongwei Yang, Wenkun Fu, Qiongzi Huang, Dongqing Zhang, Jue Wang, Wei Wang, Yingbin Wang, Tong Cheng, Ningshao Xia, 2021: Development of A Neonatal Mouse Model for Coxsackievirus B1 Antiviral Evaluation, Virologica Sinica, 36, 1575-1584. doi: 10.1007/s12250-021-00444-1
[9]
Ting Tu, Jianbo Zhan, Danlei Mou, Wei Li, Bin Su, Tong Zhang, Tao Li, Ning Li, Hao Wu, Cong Jin, Huabiao Chen, 2017: In vitro inhibition of HIV-1 replication in autologous CD4⁺ T cells indicates viral containment by multifactorial mechanisms, Virologica Sinica, 32, 485-494. doi: 10.1007/s12250-017-3992-9
[10]
Yufei Zhang, Jing Shi, Shuying Liu, 2015: Recent advances in the study of active endogenous retrovirus envelope glycoproteins in the mammalian placenta, Virologica Sinica, 30, 239-248. doi: 10.1007/s12250-015-3617-0
[11]
Zhi-Tao WAN, Xu-lin CHEN, 2010: Mechanisms of HIV envelope-induced T lymphocyte apoptosis, Virologica Sinica, 25, 307-315. doi: 10.1007/s12250-010-3148-7
[12]
Xue-ling WU, Chun-tao ZHANG, Xiao-ke ZHU, You-chun WANG, 2010: Detection of HPV Types and Neutralizing Antibodies in Women with Genital Warts in Tianjin City, China, Virologica Sinica, 25, 8-17. doi: 10.1007/s12250-010-3078-4
[13]
Qing-mao GENG, Han-ping LI, Zuo-yi BAO, Yong-jian LIU, Dao-min ZHUANG, Lin LI, Si-yang LIU, Jing-yun LI, 2010: Indinavir Resistance Evolution in One Human Immunodeficiency Virus Type 1 Infected Patient Revealed by Single-Genome Amplification^*, Virologica Sinica, 25, 316-328. doi: 10.1007/s12250-010-3122-4
[14]
Yingshuo Ma, Man Li, Lyu Xie, Na Gao, Dongying Fan, Kaihao Feng, Yao Yao, Yong Zhou, Ziyang Sheng, Hongning Zhou, Hui Chen, Jing An, 2021: Seroepidemiologic Study on Convalescent Sera from Dengue Fever Patients in Jinghong, Yunnan, Virologica Sinica.
[15]
Xin MA, Cai-jun SUN, Feng LI, Ling CHEN, 2007: HIV Vaccine-Challenges and Opportunities, Virologica Sinica, 22, 486-492.
[16]
Peng-cheng Yu, Akira Noguchi, Satoshi Inoue, Qing Tang, Simon Rayner, Guo-dong Liang, 2012: Comparison of RFFIT Tests with Different Standard Sera and Testing Procedures^*, Virologica Sinica, 27, 187-193. doi: 10.1007/s12250-012-3247-8
[17]
Jiang-Fan Li, Lei He, Yong-Qiang Deng, Shu-Hui Qi, Yue-Hong Chen, Xiao-Lu Zhang, Shi-Xiong Hu, Rui-Wen Fan, Guang-Yu Zhao, Cheng-Feng Qin, 2021: Generation and Characterization of a Nanobody Against SARS-CoV, Virologica Sinica, 36, 1484-1491. doi: 10.1007/s12250-021-00436-1
[18]
许铭炎, 马军, 洪坤学, 邓小玲, 刘永超, 阮玉华, 邢辉, 张远志, 徐小虎, 邵一鸣, 2005: HLA-B Alleles Associated with Susceptibility or Resistance to Human Immunodeficiency Virus Type 1 in a Xinjiang Uygur Population, China, Virologica Sinica, 20, 594-599.
[19]
Chun-yu YIN, Hong-zhou LU, Wei-ming JIANG, Maria Pia De Pasquale, Yue-kai HU, Xiao-zhang PAN, Xin-hua WENG, Richard T. D'Aquila, Yi-Wei TANG, 2007: Differences in Variation of Human Immunodeficiency Virus Type 1 Sequences from Henan and Shanghai Regions of China, Virologica Sinica, 22, 212-217.
[20]
毛春生, 金宁一, 佟明华, 郭军庆, 王秀清, 郭志儒, 殷震, 1998: Effects of long terminal repeat (LTR) of human immunodeficiency virus type 1 on the expression of gag gene in recombinant vaccinia viruses, Virologica Sinica, 13, 207-.